COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,580 Articles (22,415 medRxiv, 8,165 bioRxiv)

Most recent first Previous |  Page 1805: Articles 18041-18050  | Next

Harnessing testing strategies and public health measures to avert COVID-19 outbreaks during ocean cruises
Chowell, G., Dahal, S., Bono, R., Mizumoto, K.
10.1101/2021.01.24.21250408 — Posted: 2021-01-25
Association between clinical characteristics and laboratory findings with outcome of hospitalized COVID-19 patients, a report from northeast of Iran
Sobhani, S., Aryan, R., Kalantari, E., Soltani, S., Malek, N., Pirzadeh, P., Yarahmadi, A., Aghaee, A.
10.1101/2021.01.23.21250359 — Posted: 2021-01-25
Mask adherence and rate of COVID-19 across the United States
Fischer, C. B., Adrien, N., Silguero, J. J., Hopper, J. J., Chowdhury, A. I., Werler, M. M.
10.1101/2021.01.18.21250029 — Posted: 2021-01-25
An effect of the COVID-19 pandemic: significantly more complicated appendicitis due to delayed presentation of patients!
Burgard, M., Cherbanyk, F., Nassiopoulos, K., Malekzadeh, S., Pugin, F., Egger, B.
10.1101/2021.01.23.21250358 — Posted: 2021-01-25
mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants
Wu, K., Werner, A. P., Moliva, J. I., Koch, M., Choi, A., Stewart-Jones, G. B. E., Bennett, H., Boyoglu-Barnum, S., Shi, W., Graham, B. S., Carfi, A., Corbett, K. S., Seder, R. A., Edwards, D. K.
10.1101/2021.01.25.427948 — Posted: 2021-01-25 Discussion: Offsite
Host-directed therapies against early-lineage SARS-CoV-2 retain efficacy against B.1.1.7 variant
Reuschl, A.-K., Thorne, L., Zuliani Alvarez, L., Bouhaddou, M., Obernier, K., Soucheray, M., Turner, J., Fabius, J., Nguyen, G. T., Swaney, D., Rosales, R., White, K. M., Aviles, P., Kirby, I. T., Melnyk, J. E., Shi, Y., Zhang, Z., Shokat, K., Garcia-Sastre, A., Jolly, C., Towers, G. J., Krogan, N. J.
10.1101/2021.01.24.427991 — Posted: 2021-01-24
Six-month Neurological and Psychiatric Outcomes in 236,379 Survivors of COVID-19
Taquet, M., Geddes, J. R., Husain, M., Luciano, S., Harrison, P. J.
10.1101/2021.01.16.21249950 — Posted: 2021-01-24 Discussion: Onsite | Offsite
An Autoantigen Atlas from Human Lung HFL1 Cells Offers Clues to Neurological and Diverse Autoimmune Manifestations of COVID-19
Wang, J. Y., Zhang, W., Roehrl, M. W., Roehrl, V. B., Roehrl, M. H.
10.1101/2021.01.24.427965 — Posted: 2021-01-24
Meta-analysis reveals consistent immune response patterns in COVID-19 infected patients at single-cell resolution
Garg, M., Li, X., Moreno Cortez, P. A., Papatheodorou, I., Shu, Y., Brazma, A., Miao, Z.
10.1101/2021.01.24.427089 — Posted: 2021-01-24
Variation analysis of SARS-CoV-2 complete sequences from Iran
Moradi, J., Moghoofei, M., Alvandi, A. H., Abiri, R.
10.1101/2021.01.23.427885 — Posted: 2021-01-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).